Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (CYTO)

https://www.altamiratherapeutics.com

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/06/2014

Market Cap

2,240,240

Shares Outstanding

1,420,000

Weighted SO

1,417,824

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

PYXS --.--%

ZURA --.--%

EFTR --.--%

ELEV --.--%

IMMX --.--%

ENVB --.--%

PALI --.--%

CNSP --.--%

Beta

2.4260

Last Div

0.0000

Range

0.79-17.2

Chg

-0.0100

Avg Vol

1293554

Mkt Cap

2240240

Exch

NASDAQ

Country

BM

Phone

441 295 5950

DCF Diff

-0.2082

DCF

1.2082

Div Yield

0.0000

P/S

18.4283

EV Multiple

-1.7302

P/FV

0.0282

Div Yield %

0.0000

P/E

-0.0336

PEG

-0.0003

Payout

0.0000

Current Ratio

1.3760

Quick Ratio

1.4602

Cash Ratio

0.6946

DSO

258.9399

DIO

-128.7121

Op Cycle

130.2278

DPO

710.6423

CCC

-580.4145

Gross Margin

-1.0118

Op Margin

-43.4849

Pretax Margin

-51.2985

Net Margin

-51.3989

Eff Tax Rate

-0.0020

ROA

-0.7046

ROE

-2.3396

ROCE

-0.6739

NI/EBT

1.0020

EBT/EBIT

1.1797

EBIT/Rev

-43.4849

Debt Ratio

0.0130

D/E

0.0154

LT Debt/Cap

0.0000

Total Debt/Cap

0.0152

Int Coverage

-7.8483

CF/Debt

-77.4185

Equity Multi

1.1913

Rec Turnover

1.4096

Pay Turnover

0.5136

Inv Turnover

-2.8358

FA Turnover

1.3165

Asset Turnover

0.0137

OCF/Share

-36.7481

FCF/Share

-36.7481

Cash/Share

2.9407

OCF/Sales

-73.1530

FCF/OCF

1.0000

CF Coverage

-77.4185

ST Coverage

-77.4185

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.0282

P/B

0.0282

P/S

18.4283

P/E

-0.0336

P/FCF

-0.2519

P/OCF

-0.0236

P/CF

-0.0236

PEG

-0.0003

P/S

18.4283

EV Multiple

-1.7302

P/FV

0.0282

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 08, 08:47 Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit GlobeNewswire Inc. Dec 29, 08:47 Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire Inc. Dec 29, 08:47 Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire Inc. Dec 05, 12:54 Altamira Therapeutics to Host Investor & Business Update Call on December 11th MarketWatch Nov 30, 09:33 These advisers say markets are expecting unrealistic outcomes. Here are some alternatives. GlobeNewswire Inc. Nov 29, 10:20 Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement PennyStocks Nov 20, 10:17 Best Penny Stocks To Buy This Week? 4 To Watch Now Benzinga Nov 17, 13:01 Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session PennyStocks Nov 17, 11:19 Penny Stocks To Buy? 4 Under $5 To Watch Right Now GlobeNewswire Inc. Nov 17, 09:04 Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business GlobeNewswire Inc. Nov 10, 08:47 Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine

Revenue Product Segmentation